Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$92.49+0.54 (+0.59%)
Close on Nov 18, 2026Market cap $6.01BP/E –Yield –
Mirum Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Mirum Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$227.27M, down 2626.6% year over year. For fiscal 2025 it was $55.83M, up 440.7% from the year before. The highest annual figure on record is $55.83M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.83M | +440.7% |
| FY2024 | Dec 31, 2024 | $10.33M | – |
| FY2023 | Dec 31, 2023 | -$70.94M | – |
| FY2022 | Dec 31, 2022 | -$120.14M | – |
| FY2021 | Dec 31, 2021 | -$132.76M | – |
| FY2020 | Dec 31, 2020 | -$89.08M | – |
| FY2019 | Dec 31, 2019 | -$39.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$44.25M | -467.5% |
| Q1 FY2026 | Mar 31, 2026 | -$228.76M | – |
| Q4 FY2025 | Dec 31, 2025 | $6.07M | – |
| Q3 FY2025 | Sep 30, 2025 | $39.68M | +896.0% |
| Q2 FY2025 | Jun 30, 2025 | $12.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.96M | -112.9% |
| Q4 FY2024 | Dec 31, 2024 | -$5.07M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.98M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.80M | – |
| Q1 FY2024 | Mar 31, 2024 | $15.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.62M | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.27M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.03M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.17M | – |
| Q1 FY2022 | Mar 31, 2022 | -$39.67M | – |
| Q4 FY2021 | Dec 31, 2021 | -$33.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$34.20M | – |
| Q2 FY2021 | Jun 30, 2021 | -$40.20M | – |
| Q1 FY2021 | Mar 31, 2021 | -$25.21M | – |
| Q4 FY2020 | Dec 31, 2020 | -$36.28M | – |
| Q3 FY2020 | Sep 30, 2020 | -$17.45M | – |
| Q2 FY2020 | Jun 30, 2020 | -$16.99M | – |
| Q1 FY2020 | Mar 31, 2020 | -$18.35M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.70M | – |
| Q3 FY2019 | Sep 30, 2019 | -$15.22M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.43M | – |
See a number that looks wrong?